Moreover, Yamashita et al.31 and Maruyama et al.32 presented evidence that OPTN is associated with TDP-43 and that TDP-43-positive inclusions showed positive immunolabelling with anti-OPTN antibodies in the muscles of patients with sporadic inclusion body myositis and sporadic ALS. This evidence concerns the gene TARDBP and inclusion body myositis.